Background: Suicide rates among people living with HIV/AIDS (PLHIV) have been reported at markedly higher levels than in the general population. We sought to evaluate this trend and identify factors associated with suicide among PLHIV who have initiated Highly Active Antiretroviral Therapy (HAART) in British Columbia (BC), Canada. Methodology: Our analysis was based on all treatment naive individuals who initiated HAART in BC from August 1996 to June 2012. Data on deaths were ascertained from monthly linkages with the BC Vital Statistics Registry. Logistic regression and Cox Proportional hazard models were used to identify factors independently associated with suicide mortality. Suicide was defined by any of the following ICD-10 “cause of death” codes: E850-E854, E858, E862, E868; X40-X42, X46, X47; Y10-Y12, Y16, Y17; E950-E952, X60-X69: E953, X70; E954, X71; E955, X72-X75; E958.1, E958.2; X76, X77; E956; X78, X79: E957, X80; E958.0, X81; E958.5, X82; E958.3, E958.4, E958.6-E958.9; X83, X84. The variables assessed included: gender, Aboriginal identity, median income, urban versus rural neighborhood, age at death and year of death, ever having been diagnosed with an AIDS-defining illness, ever having had a positive hepatitis C (HCV) diagnosis, HAART adherence in the most recent year, most recent HAART cocktail, number of years on HAART, most recent and nadir CD4, most recent viral load, and history of injection drug use. Results: Among 5,229 PLHIV who initiated HAART over the study period, 993 (19%) died, of which 82 (8.2%) were from suicide. In 1998, suicide mortality peaked at 961 deaths per 100,000 person-years, a rate 91-fold greater than in the BC population, and then declined to 28 deaths per 100,000 person years in 2010, a rate 3-fold greater than the BC population. No deaths from suicide were reported in 2011, which was the last full year of data for the cohort. The Cox model, which included those who committed suicide and those who remained alive at the end of the study period (n =4318), showed that a history of injection drug use (Adjusted Hazard Ratio [AHR ]= 3.95; 95% CI: 1.99-7.86) and never having been diagnosed with an AIDS defining illness (AHR = 4.45; 95% CI: 1.62 – 12.25) were independently associated with time to suicide. Conclusions: Rates of deaths from suicide declined significantly over the study period. While factors directly related to HIV infection, or type of HAART regimen, were not associated with suicide, other factors related to life style issues, like injection drug use, were.